IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $132,000 | -30.9% | 12,050 | +6.7% | 0.00% | – |
| Q1 2022 | $191,000 | -3.5% | 11,291 | +8.2% | 0.00% | – |
| Q4 2021 | $198,000 | -28.0% | 10,436 | -5.9% | 0.00% | -100.0% |
| Q3 2021 | $275,000 | -25.3% | 11,094 | -21.8% | 0.00% | 0.0% |
| Q2 2021 | $368,000 | +62.1% | 14,187 | +88.3% | 0.00% | 0.0% |
| Q1 2020 | $227,000 | -26.3% | 7,535 | -42.5% | 0.00% | -50.0% |
| Q2 2019 | $308,000 | – | 13,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |